Tag: Medical

Tandem Diabetes Care
Global

Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

November 01, 2023 04:06 PM Eastern Daylight Time SAN DIEGO–(BUSINESS WIRE)–Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, today announced the appointment of Mark Novara as Executive Vice President and Chief Commercial Officer, effective November 13, 2023. Mr. Novara comes to Tandem with extensive global healthcare experience, having served in the diabetes, medical technology, and life sciences industries for … Continue reading Tandem Diabetes Care Appoints Mark Novara as EVP and Chief Commercial Officer

Impact Newswire
PHARMAJET
Global, United States

Daicel Group Invests in PharmaJet

October 31, 2023 11:10 AM Eastern Daylight Time GOLDEN, Colo.–(BUSINESS WIRE)–PharmaJet®, a company that engineers precision delivery systems that overcome the challenges of vaccines and pharmaceuticals delivery, today announced that it received a strategic investment from the Daicel Corporation. This investment coincides with Daicel’s announcement of the establishment of a new company, Daicel Medical Ltd., and reinforces Daicel’s commitment to growth in this critical area of … Continue reading Daicel Group Invests in PharmaJet

Impact Newswire
UPWARD HEALTH
Global, United States

Upward Health Announces Appointment of New Chief Financial Officer

October 25, 2023 10:00 AM Eastern Daylight Time HAUPPAUGE, N.Y.–(BUSINESS WIRE)–Upward Health, a risk-bearing, in-home medical group, today announced the appointment of Benjamin Hamawy to Chief Financial Officer.   “The opportunity for value creation is tremendous given the talent, drive, and passion of the team. I am confident that together we can develop and implement financial strategies to further support Upward Health’s expansion plans.”Tweet this … Continue reading Upward Health Announces Appointment of New Chief Financial Officer

Impact Newswire
LEO PHARMA
Europe

Globally Known Professor and Dermatologist Joins LEO Pharma

Ahead of EADV, LEO Pharma announces that Professor Alexander Egeberg, a board-certified dermatologist, and top key opinion leader, will join the company as Head of Global Medical Affairs. October 09, 2023 04:00 AM Eastern Daylight Time BALLERUP, Denmark – LEO Pharma A/S, a global leader in medical dermatology, is today announcing the appointment of Professor Alexander Egeberg, a globally recognized dermatologist and top key opinion … Continue reading Globally Known Professor and Dermatologist Joins LEO Pharma

Impact Newswire
LIVANOVA
Untied Kingdom

LivaNova Board Appoints J. Christopher Barry as New Director

Long-time Director Andrea Saia to retire from the Board October 06, 2023 08:30 AM Eastern Daylight Time LONDON – LivaNova PLC (Nasdaq: LIVN), a market-leading medical technology company, announced its Board of Directors has appointed J. Christopher Barry to the Board, effective today. Barry will serve on the Audit and Compliance Committee. Andrea Saia, who has served as a Director since 2016, will retire from … Continue reading LivaNova Board Appoints J. Christopher Barry as New Director

Impact Newswire
AmbioPharm
United States

AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

October 02, 2023 06:00 AM Eastern Daylight Time NORTH AUGUSTA, S.C. – AmbioPharm, a worldwide leader in peptide active pharmaceutical ingredient (API) contract development and manufacturing organization (CDMO) services, announced the appointment of industry veteran Brian Gregg as Chief Executive Officer, today. Mr. Gregg, who has more than 30 years of experience in the peptide CDMO industry, succeeds Tim Nieters, who will be stepping down … Continue reading AmbioPharm Appoints Industry Veteran Brian Gregg as CEO

Impact Newswire